Vkt Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VKT PHARMA, and what generic and branded alternatives to VKT PHARMA drugs are available?
VKT PHARMA has four approved drugs.
Drugs and US Patents for Vkt Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vkt Pharma | FAMOTIDINE | famotidine | TABLET;ORAL | 215822-002 | Jan 28, 2022 | OTC | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Vkt Pharma | RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | TABLET;ORAL | 211289-001 | Jan 31, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Vkt Pharma | RANOLAZINE | ranolazine | TABLET, EXTENDED RELEASE;ORAL | 214035-002 | Jan 19, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Vkt Pharma | TADALAFIL | tadalafil | TABLET;ORAL | 215556-001 | Nov 4, 2021 | AB1 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.